Skip to main content
European Journal of Hospital Pharmacy logoLink to European Journal of Hospital Pharmacy
. 2016 Nov 22;24(6):361–365. doi: 10.1136/ejhpharm-2016-001083

Towards patient safety: assessment of medication errors in the intensive care unit in a developing country’s tertiary care teaching hospital

Sri Harsha Chalasani 1, Madhan Ramesh 1
PMCID: PMC6451462  PMID: 31156972

Abstract

Objectives

To determine the incidence, causes, patterns and outcomes of medication errors (MEs) in the intensive care unit.

Methods

The ME reporting system was established using the principles based on prospective, voluntary, open, anonymous and stand-alone surveillance in a tertiary care teaching hospital located in southern India. MEs involving patients of either sex were included in the study, and the reporters were given the choice to remain anonymous. The analysis was carried out to determine the patterns, causes and outcomes of the reported errors and was discussed with healthcare professionals (HCPs) to minimise the recurrence of MEs.

Results

A total of 292 MEs were reported voluntarily among 5137 admitted patients and the incidence of MEs was 5.6%. Administration errors (n=143, 49%) were the most common type of MEs reported followed by prescription errors (n=56, 19%) and dispensing errors (n=43, 15%). Factors responsible for MEs were related to performance deficit of HCPs due to excessive workload, fatigue, unclear interpersonnel communications and patient-related factors, which accounted for 37.6%, 13.1%, 9.6% and 7.7%, respectively. The majority of the reported MEs had an outcome of category C and A, based on the National Coordinating Council for ME Reporting and Prevention (NCC MERP) outcome category scale, amounting to 42.2% and 41.7%, respectively.

Conclusions

Although the majority of MEs that reached the patients did not cause any harm, providing continuous education and awareness of MEs to HCPs and patients may minimise the scope of the factors that may contribute to MEs and improve overall patient safety.

Keywords: Medication Errors, Medication Errors in ICU, Medication Errors in Developing Country, Medication Error Rporting Programme, Clinical Pharmacist initiated medication error reporting programme, CLINICAL PHARMACY


EAHP Statement 4: Clinical Pharmacy Services

Introduction

Medication errors (MEs) compromise patient safety. In the current work setting, multiple unavoidable factors such as workload, fatigue, work extended hours, sleep deprivation, environmental, professional sanctions and newly inducted staff may contribute knowingly or unknowingly towards MEs and thus jeopardise the patient’s safety.1–3 The concern of stakeholders in the healthcare profession on the importance of patient safety started to increase with the advent of the 1999 Institute of Medicine’s (IOM) report “To Err is Human: Building a Safer Health System”. We have little evidence that patient safety has improved since then.3–5 Critically ill patients admitted to intensive care units (ICUs) receive twice as many medications as patients admitted to other units.2 This situation potentially increases the risk of iatrogenic injury. Evidence suggests that MEs account for 78% of severe outcomes, with an average estimate of 1.7 MEs each day per patient. Of those, many patients suffer potentially life-threatening errors during their stay in critical care units.6–9 Furthermore, there are as many as 80–200 steps involved in administering a single dose to a critically ill patient–encompassing domains of prescribing, transcribing, dispensing, administering, documenting, monitoring and storing–providing a sufficient window for MEs to occur.10 11

It has been more than two decades since Leape highlighted the need to gather comprehensive patient information and restructure hospital data systems to minimise errors in healthcare; however, the use of Computerised Physician Order Entry (CPOE) systems is modest even today.12 13 Overall, ME rates in hospitals range from 4.4% to 59.1% worldwide. However, reporting of these errors is less than 5% around the globe. There are many reasons for under-reporting of these errors, including the punitive course of actions, fragile systems of patient safety and financial constraints. It is estimated that North America spends 37.6 billion dollars each year on managing MEs and another 17 billion dollars on preventing medication mistakes.14 Researchers across the world have proposed specialised programmes such as the Systems Engineering Initiative for Patient Safety model, CPOE systems and Healthcare Information Technology for Economic and Clinical Health (HITECH) to reduce MEs. As mentioned earlier, the information on efficient utilisation of systems in preventing MEs is currently limited,13–15 which could be due primarily to a lack of nationalised ME reporting programmes. In 2006 only 12 countries had signed the Salamanca Declaration intended to promote safe medication practices globally, and by 2007 there were 11 nations either with national or local ME reporting systems. However, India is not one of them.16 17

The most common risk factors for MEs in developing countries are inefficient communication systems in hospitals and illegible prescriptions.18 An ME reporting programme was initiated in the ICU of the study healthcare setting to understand and assess the pattern, risk factors and outcomes of reported MEs.

Materials and methods

The study was conducted using a newly established ME reporting centre in the ICU of a tertiary care teaching hospital providing healthcare facilities to people residing in and around the Mysuru district of southern India. The ME reporting system was designed to be a voluntary, open, stand-alone and anonymous reporting system and data were collected for 6 months (April–September 2015). Patients of either sex aged ≥18 years admitted to the ICU were included. All the relevant information was documented on a suitably designed ME reporting form (see online supplementary file 1).

supplementary file

ejhpharm-2016-001083supp001.pdf (178.5KB, pdf)

Identification and assessment of MEs

The case records of inpatients were reviewed on a daily basis to identify medication mistakes which the ME review committee later quantified.

Upon reporting an error, data about the incident including (but not limited to) the description of the suspected medicine involved, date the problem was identified and type of formulation were collected. Information on the personnel involved (optional) and contributing human factors leading to the ME were obtained from the personnel and various data sources such as case notes, medication treatment charts, prescriptions and further documented in a suitably designed ME assessment form.

The patterns of identified MEs were categorised as a prescription error, transcription error, dispensing error, administration error, nursing staff notes documentation error, medication storage error, medication monitoring error and procurement error. The outcomes were categorised based on the severity according to the National Coordinating Council for ME Reporting and Prevention (NCC MERP)19 (figure 1).

Figure 1.

Figure 1

National Coordinating Council for Medication Error Reporting and Prevention’s index for categorising medication errors.

Results

During the study period 5137 patients were admitted to the ICU. A total of 292 MEs were voluntarily identified and reported by various medical professionals. Of the 292 MEs, 194 (66.4%) were recognised and communicated by the healthcare professionals (HCPs) and 98 (33.5%) were reported through intensive follow-up with other HCPs (table 1).

Table 1.

Overall distribution of medication errors identified and reported by healthcare professionals (HCPs)

Sl. no Category of HCP No (%) medication errors reported
1 Doctors 72 (24.6)
2 Nurses 122 (41.7)
3 Research pharmacists 98 (33.5)
Total 292 (100)

Sl. No., serial number.

As shown in table 2, drug administration errors were the most common, accounting for 105 (35.9%) of the 292 errors, followed by prescribing and dispensing errors.

Table 2.

Categories of medication errors reported by various healthcare professionals

Category of reporter
Sl. no Category of error Doctor Nurse Clinical pharmacist Total no (%) of errors
1 Prescription 2 2 52 56 (19.1)
2 Transcription 6 5 6 17 (5.8)
3 Dispensing 11 19 13 43 (14.7)
4 Administration 33 58 14 105 (35.9)
5 Documentation 7 9 1 17 (5.8)
6 Procurement 4 17 12 33 (11.3)
7 Monitoring 8 11 0 19 (6.5)
8 Storage 1 1 0 2 (0.6)
Total (%) 72 (24.6) 122 (41.7) 98 (33.5) 292 (100)

Sl. No., serial number.

The detailed distributions of the reported MEs are shown in table 3; medication administration errors were the most frequent (48.9%).

Table 3.

Detailed distribution of medication errors under each category

Sl. no Category Subcategory of errors No (%) of errors
1 Prescription Incompleteness 54 (18.4)
Illegible 2 (0.6)
Total 56 (19.1)
2 Transcription Incompleteness 2 (0.6)
Illegible 15 (5.1)
Total 17 (5.8)
3 Dispensing Wrong drug 11 (3.7)
Wrong strength 0
Wrong dosage form 0
Wrong quantity
 Fewer 5 (1.7)
 More 1 (0.3)
Other brand 12 (4.1)
Delayed dispensing 14 (4.7)
Total 43 (14.7)
4 Administration Wrong drug 1 (0.3)
Wrong strength 5 (1.7)
Wrong dosage form 0
Wrong time
 Prolonged >1 hour 81 (27.7)
 Administered before 1 hour 3 (1)
Wrong administration technique 8 (2.7)
Wrong patient 0
Dose missed 7 (2.3)
Documentation
 Incomplete documentation 15 (5.1)
 Delayed documentation 2 (0.6)
Monitoring 19 (6.5)
Storage 2 (0.6)
Total 143 (48.9)
5 Procurement Failure to bring 23 (7.8)
Insufficient quantities 4 (1.3)
Substituted with other brands 3 (1)
Time taken to procure >12 hours 3 (1)
Total 33 (11.3)
Grand total 292 (100)

Sl. No., serial number.

Of the 292 errors reported, 201 (68.8%) and 91 (31.1%) errors were found in the intensive care ward and attached pharmacy, respectively (table 4).

Table 4.

Distribution of outcome of medication errors according to the National Coordinating Council for Medication Error Reporting and Prevention

Sl. no. Place where errors originated Category A
n (%)
Category B
n (%)
Category C
n (%)
Category D
n (%)
1 Pharmacy 74 (25.3) 6 (2) 11 (3.7) 0 (0)
2 Wards 48 (16.4) 14 (4.7) 113 (38.6) 26 (8.9)
Total 122 (41.7) 20 (6.8) 124 (42.4) 26 (8.9)
Grand total 292 (100)

Sl. No., serial number.

In most cases, workload (n=117, 37.6%) was the prime reason or contributing factor for the medication incident to occur. Fatigue and lack of communication were the second and third most common contributing factors (table 5).

Table 5.

Distribution of contributing factors towards reported medication errors

No Contributing factors No of errors
1 Communications 30
2 Distractions 20
3 Workload 117
4 Peak hours 14
5 Fatigue 41
6 Documentation 2
7 Inadequate monitoring 14
8 Patient-related factors 24
9 Calculation errors 4
10 Illegible prescriptions 16
11 New staff 6
12 Knowledge deficient 17
13 Emergency situation 6
Total 311

Discussion

The investigation of MEs in the current framework of the healthcare system across the world is not well perceived and widely accepted. Great caution was exercised at the study site to deliver this programme, with emphasis on the virtues of voluntary, non-punitive, stand-alone and anonymous reporting and not to fault-find with any individual involved in the error. Although the rate of reporting in the initial stages was slow, it has gradually improved. HCPs voluntarily reported 292 errors among the 5137 admitted patients. Of the reported 292 errors, 194 (66.4%) were identified and communicated by HCPs other than a clinical pharmacist and 98 (33.5%) through intensive follow-up. The yardstick of the programme’s success would be HCPs voluntarily adopting the open reporting system rather than anonymously by coming forward to discuss reported errors openly within the healthcare system. Although an electronic format of reporting was made available to report MEs through a voluntary ME reporting system under the Hospital Information Systems (HIS), HCPs have preferred to communicate through the paper-based system.

Medication administration errors were the most commonly reported MEs (n=105, 35.9%), and these results were in contrast to the results of a study conducted by Raju et al 20 where medication administration errors comprised 60% of all reported MEs. This situation warrants arrangements for continuous education programmes on prevention of MEs for nursing staff as they spend 40% of their time on drug administration, and the evidence suggests that one in three MEs were due to the nursing staff’s medication administration.21–23

The number of prescription errors (n=56, 19.1%) was lower than in other published studies. In a systematic review, Reckmann et al proposed the reduction of MEs on similar lines with the use of the CPOE system. Although CPOE reduces the incidence of prescription and dispensing errors, the design used in developing the CPOE algorithm may affect the outcomes in preventing MEs—that is, when an algorithm is not programmed robustly to adopt CPOE dynamically, there would be a minimal impact on the reduction of MEs.24

We observed similar findings to those of Radley et al 14 who found that CPOE reduced MEs by 48%. However, the use of the existing CPOE system was modest at the study site. Although an electronic system was made available for prescribing medicines and reporting MEs at the study site, the use of the system was minimal. Of the total 72 MEs reported by doctors, most errors were observed to have occurred during medication administration (n=33, 11.3%), followed by dispensing (n=11, 3.7%), monitoring (n=8, 2.7%) and transcription (n=6, 2%). Of the 122 (4.7%) errors reported by nurses, most occurred during administration (n=58, 19.8%), followed by dispensing (n=19, 6.5%), procurement (n=17, 5.8%), monitoring (n=11, 3.7%), and the rest during documentation (n=9, 3%), transcription (n=5, 1.7%), prescription (n=2, 0.6%) and storage (n=1, 0.3%).

A significant proportion of MEs occurred during medication administration (n=143, 48.9%), most of which occurred due to administration at the wrong time (n=84, 28.7%). The study by Kirmani25 reported similar results to those of our study, with 13% of MEs caused by delayed dose administrations of medications regarding drug administration at the wrong time, followed by insufficient monitoring of high alert medications (n=19, 6.5%), incomplete documentation (n=17, 5.8%), wrong administration rate (n=8, 2.7%), missed dose (n=7, 2.3%) and inappropriate storage (n=2, 0.6%). Prescription errors contributed to 56 errors (19.1%), which included errors due to incompleteness (n=54, 18.4%) and illegibility (n=2, 0.6%). Errors in dispensing contributed to 43 (14.7%) of the 292 errors reported, which included delayed dispensing of medications (n=14, 4.7%), inappropriate medication brand substitution (n=12, 4.1%), wrong drug dispensing (n=11, 3.7%) and dispensing the wrong quantity (n=6, 2%). Medication procurement errors accounted for 11.3% of the total MEs. These errors included failure to bring the drugs to the patient by their caregivers (n=23, 7.8%), delivery of insufficient quantities of medicines (n=4, 1.3%), substitution with other brands (n=3, 1%) and delay in the procurement of medicines due to economic considerations (n=3, 1%). Medications purchased from outside the hospital might contribute to the occurrence of MEs.26 The National President of the Pharmaceutical Society of Australia has suggested that brand substitution may lead to MEs.27

Transcription errors were observed in 17 MEs (5.8%), which included errors due to illegibility (n=15, 5.1%) and incompleteness of prescriptions (n=2, 0.6%). These results were in contrast to a study conducted by Fahimi et al 28 where transcriptional errors accounted for 52% of MEs.

Most reports indicate that workload is a prime reason for the occurrence of MEs (n=117, 37.6%). Of the listed contributing factors, workload, fatigue, sleep deprivation and peak hours are considered to be factors that contribute towards MEs.

Conclusion

The voluntary reporting of MEs was slow and most of the errors identified in the study did not cause any harm. To minimise these MEs, reporting systems should be designed to encourage HCPs by conducting awareness and education programmes, assuring a non-punitive and reward-based system, thus promoting patient safety.

What this paper adds.

What is already known on this subject

  • Medication errors occur at every stage of healthcare and jeopardise patient safety.

  • Under-reporting of medication errors is prevalent and only a few countries have medication error reporting programmes.

  • In developing countries the prevalence of medication errors is unknown.

What this study adds

  • A culture of voluntary medication error reporting can be fostered among healthcare workforces in developing countries through non-punitive policies.

  • Dynamic work ratio of healthcare professionals (HCPs) can increase the rate of medication errors.

  • Clinical pharmacists can assist HCPs to promote patient safety.

Acknowledgments

The authors thank the Principal of JSS College of Pharmacy, JSS University, Mysuru and the staff of the intensive care unit and hospital for their co-operation and support.

Footnotes

Contributors: SHC: Design of the study, development of data collection forms, data collection, data analysis, preparation of manuscript and submission of the manuscript. MR: Design of the study, development of data collection forms, data analysis, preparation of manuscript and submission of the manuscript.

Funding: Funding was supplied by the Department of Science and Technology’s INSPIRE Fellowship, Government of India to SHC.

Competing interests: None declared.

Ethics approval: Ethics approval was obtained from the Institutional Ethics Committee, JSS College of Pharmacy, Mysuru, Karnataka, India.

Provenance and peer review: Not commissioned; externally peer reviewed.

References

  • 1. Sahithi KH, Mohammad I, Reddy JM, et al. Assessment of medication errors in psychiatry practice in a Tertiary Care Hospital. Int J Pharm Sci Res 2015;6:226–32. 10.13040/IJPSR.0975-8232.6(1).226-32 [DOI] [Google Scholar]
  • 2. Moyen E, Camiré E, Stelfox HT. Clinical review: medication errors in critical care. Crit Care 2008;12:208 10.1186/cc6813 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Landrigan CP, Rothschild JM, Cronin JW, et al. Effect of reducing interns’ work hours on serious medical errors in intensive care units. N Engl J Med 2004;351:1838–48. 10.1056/NEJMoa041406 [DOI] [PubMed] [Google Scholar]
  • 4. Kohn LT, Corrigan JM, Donaldson MS. To err is human: building a safer health system. Washington: National Academy Press, 1999. [PubMed] [Google Scholar]
  • 5. Stelfox HT, Palmisani S, Scurlock C, et al. The ‘To Err is Human’ report and the patient safety literature. Qual Saf Health Care 2006;15:174–8. 10.1136/qshc.2006.017947 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Leape LL, Berwick DM. Five years after To Err Is Human: what have we learned? JAMA 2005;293:2384–90. 10.1001/jama.293.19.2384 [DOI] [PubMed] [Google Scholar]
  • 7. Rothschild JM, Landrigan CP, Cronin JW, et al. The Critical Care Safety Study: the incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med 2005;33:1694–700. 10.1097/01.CCM.0000171609.91035.BD [DOI] [PubMed] [Google Scholar]
  • 8. Donchin Y, Gopher D, Olin M, et al. A look into the nature and causes of human errors in the intensive care unit. Crit Care Med 1995;23:294–300. 10.1097/00003246-199502000-00015 [DOI] [PubMed] [Google Scholar]
  • 9. Pronovost PJ, Thompson DA, Holzmueller CG, et al. Defining and measuring patient safety. Crit Care Clin 2005;21:1–19, vii 10.1016/j.ccc.2004.07.006 [DOI] [PubMed] [Google Scholar]
  • 10. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study Group. JAMA 1995;274:29–34. [PubMed] [Google Scholar]
  • 11. Pharmacy-nursing shared vision for safe medication use in hospitals: executive summary session. Am J Health Syst Pharm 2003;60:1046–52. [DOI] [PubMed] [Google Scholar]
  • 12. Hussain E, Kao E. Medication safety and transfusion errors in the ICU and beyond. Crit Care Clin 2005;21:91–110. 10.1016/j.ccc.2004.08.003 [DOI] [PubMed] [Google Scholar]
  • 13. Leape LL. Error in medicine. JAMA 1994;272:1851–7. 10.1001/jama.1994.03520230061039 [DOI] [PubMed] [Google Scholar]
  • 14. Radley DC, Wasserman MR, Olsho LE, et al. Reduction in medication errors in hospitals due to adoption of computerised provider order entry systems. J Am Med Inform Assoc 2013;20:470–6. 10.1136/amiajnl-2012-001241 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Ramesh M, Pallepati M, Parthasarathi G. Medication errors in clinical settings: detection and risk management. Pharma Times 2012;44:19–21. [Google Scholar]
  • 16. Khawaja K, Nizar R, Merchant RJ, et al. A systematic approach to tracking and reporting medication errors at a tertiary care university hospital, Karachi, Pakistan. Ther Clin Risk Manag 2008;4:673–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17. Terzibanjan AR, Laaksonen R, Weiss M, et al. Medication error reporting systems—lessons learnt, executive summary of findings (internet) 2007. (cited 28 Aug 2013). International Pharmaceutical Federation (FIP) https://www.fip.org/files/fip/Patient%20Safety/Medication%20Error%20Reporting%20-%20Lessons%20Learnt2008.pdf [Google Scholar]
  • 18. American Society of Hospital Pharmacists. ASHP guidelines on preventing medication errors in hospitals. Am J Hosp Pharm 1993;50:305–14. [PubMed] [Google Scholar]
  • 19. The National Coordinating Council for Medication Error Reporting and Prevention. 2014. http://www.nccmerp.org/medErrorCatIndex.html (accessed 23 May 2014).
  • 20. Raju TN, Kecskes S, Thornton JP, et al. Medication errors in neonatal and paediatric intensive-care units. Lancet 1989;2:374–6. 10.1016/S0140-6736(89)90548-5 [DOI] [PubMed] [Google Scholar]
  • 21. Hughes RG, Blegen MA. Medication administration safety. In: Hughes RG, ed. Patient safety and quality: an evidence-based handbook for nurses. Rockville, MD: Agency for Healthcare Research and Quality (US), 2008. Chapter 37. http://www.ncbi.nlm.nih.gov/books/NBK2656/ [PubMed] [Google Scholar]
  • 22. Bates DW, Boyle DL, Vander Vliet MB, et al. Relationship between medication errors and adverse drug events. J Gen Intern Med 1995;10:199–205. 10.1007/BF02600255 [DOI] [PubMed] [Google Scholar]
  • 23. Pepper GA. Errors in drug administration by nurses. Am J Health Syst Pharm 1995;52:390–5. [DOI] [PubMed] [Google Scholar]
  • 24. Reckmann MH, Westbrook JI, Koh Y, et al. Does computerised provider order entry reduce prescribing errors for hospital inpatients? A systematic review. J Am Med Inform Assoc 2009;16:613–23. 10.1197/jamia.M3050 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Kirmani SS. Prevalence and causes of wrong time medication administration errors, experience at a tertiary care hospital, Karachi, Pakistan. 18 Nov 2013. (cited 13 Jan 2015). Virginia-Henderson Global Nursing e-Repository. http://www.nursinglibrary.org/vhl/handle/10755/308540
  • 26. Abdul SS, Nguyen A, Huang F, et al. A smart medication recommendation model for the electronic prescription. COMM 2014;3825:1–7. [DOI] [PubMed] [Google Scholar]
  • 27. Kardachi G. No need for generic confusion. Aust Pharm 2012;31:81. [Google Scholar]
  • 28. Fahimi F, Nazari MA, Abrishami R, et al. Transcription errors observed in a teaching hospital. Arch Iranian Med 2009;12:173–5. [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

supplementary file

ejhpharm-2016-001083supp001.pdf (178.5KB, pdf)


Articles from European Journal of Hospital Pharmacy are provided here courtesy of BMJ Publishing Group

RESOURCES